Expression of p8 protein in medullary thyroid carcinoma

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3419-3423

  Ito, Yasuhiro ^a   Yoshida, Hiroshi ^a   Motoo, Yoshiharu ^b   Iovanna, Juan Lucio ^c   Tomoda, Chisato ^a   Uruno, Takashi ^a   Takamura, Yuuki ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Matsuzuka, Fumio ^a   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c INSERM   (France)

Author keywords

Apoptosis; Medullary thyroid carcinoma; p8

Indexed keywords

P8 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; THYROID MEDULLARY CARCINOMA; UICC STAGING;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, MEDULLARY; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; THYROID NEOPLASMS;

EID: 23344443837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ball DW, Baylin SB and de Bustros AC: Medullary thyroid carcinoma. In: Braverman LE and Utiger RD (eds.). Thyroid 8th ed. Lippincott Williams & Wilkins. Philadelphia, pp. 930-943, 2001.
2. Mulligan LM, Kwok JB, Healey C, Eisdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK and Papi L: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 2: 851-856, 1993.
3. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P and Wells SA Jr: Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2: 851-856, 1993.
4. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ and Donis-Keller H: Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91: 1579-1583, 1994.
5. Jiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM and Mazzaferri EL: RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid 6: 115-121, 1996.
6. Scopi L, Sampietro G, Boracchi P, Del Bo R, Gullo M, Placucci M and Pilotti SL: Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. Cancer 78: 2183-2183, 1996.
7. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M and Herfarth C: Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 114: 491-496, 1993.
8. Baloch ZW and LiVolsi VA: Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma. Thyroid 11: 637-645, 2001.
9. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS Jr, Hickey RC and Samaan NA: Medicine 63: 319-342, 1984.
10. Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J and Iovanna JL: Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 272: 32360-32369, 1997.
11. Vasseur S, Mallo GV, Fiedler F, Bodeker H, Canepa E, Moreno S and Iovanna JL: Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 259: 670-675, 1999.
12. Courjal F and Theillet C: Comparative genomic hybridization analysis of breast tumor with predetermined profiles of DNA amplification. Cancer Res 57: 4368-4377, 1997.
13. Su SB, Motoo Y, Iovanna JL, Xie MJ, Mouri H, Ohtsubo K, Yamaguchi Y, Watanabe H, Okai T, Matsubara F and Sawabu N: Expression of p8 in human pancreatic cancer. Clin Cancer Res 7: 309-313, 2001.
14. Su SB, Motoo Y, Iovanna JL, Berthezene P, Xie MJ, Mouri H, Ohtsubo K, Matsubara F and Sawabu N: Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. Clin Cancer Res 7: 1320-1324, 2001.
15. Ito Y, Yoshida H, Motoo Y, Miyoshi E, Iovanna JL, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matuura N, Kuma K and Miyauchi A: Expression and cellular localization of p8 protein in thyroid neoplasms. Cancer Lett 201: 237-244, 2003.
16. Ito Y, Yoshida H, Motoo Y, Iovanna JL, Nakamura Y, Kakudo K, Uruno T, Takamura Y, Miya A, Noguchi S, Kuma K and Miyauchi A: Expression of p8 protein in breast carcinoma; an inverse relationship with apoptosis. Anticancer Res 25: 833-838, 2005.
17. Vasseur S, Mallo GV, Fiedler F, Bodeker H, Canepa E, Moreno S and Iovanna JL: Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 259: 670-675, 1999.
18. Sobin LH and Wittekind Ch (eds.): 2002 UICC: TNM Classification of Malignant Tumors, 6th ed. New York: Wiley-Liss.
19. Vessour S, Hoffmeister A, Garcia S, Bagnis C, Dagorn JC and Iovanna JL: P8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene. EMBO Rep 3: 165-170, 2002.
20. Mohammad HP, Seachrist DD, Quirk CC and Nilson JH: Reexpression of p8 contributes to tumorigenic properties of pituitary cells and appears in a subset of prolactinomas in transgenic mice that hypersecrete luteinizing hormone. Mol Endocrinol 18: 2583-2593, 2004.
21. Iovanna JL: Expression of the stress-associated protein p8 is a requisite for tumor development. Int J Gastrointest Cancer 31: 89-98, 2002.
22. Path G, Opel A, Knoll A and Seufert J: Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth. Diabetes 53(S1): S82-85, 2004.